|
Volumn 49, Issue 3, 2002, Pages 307-314
|
Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism?
a a a a |
Author keywords
Antithyroid treatment; Blood pressure; BMD; Heart rate variability; Subclinical hyperthyroidism
|
Indexed keywords
ALKALINE PHOSPHATASE;
ANTITHYROID AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM;
CREATININE;
LIPID;
OSTEOCALCIN;
PHOSPHORUS;
ADULT;
ARTICLE;
BLOOD PRESSURE MONITORING;
BONE DENSITY;
BONE MINERAL;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG INDICATION;
EUTHYROIDISM;
FATIGUE;
FEMALE;
FEMUR NECK;
HEART RATE VARIABILITY;
HOLTER MONITORING;
HUMAN;
HYPERHIDROSIS;
HYPERTHYROIDISM;
KIDNEY FUNCTION TEST;
LIPID BLOOD LEVEL;
LIVER FUNCTION TEST;
LUMBAR SPINAL CORD;
MALE;
NERVOUSNESS;
RANDOMIZED CONTROLLED TRIAL;
TACHYCARDIA;
TREATMENT OUTCOME;
BLOOD PRESSURE;
DRUG EFFECT;
HEART ARRHYTHMIA;
HEART RATE;
HOSPITALIZATION;
MIDDLE AGED;
PATHOPHYSIOLOGY;
ADULT;
ANTITHYROID AGENTS;
ARRHYTHMIA;
BLOOD PRESSURE;
BONE DENSITY;
FEMALE;
HEART RATE;
HUMANS;
HYPERTHYROIDISM;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
|
EID: 0036022450
PISSN: 09188959
EISSN: None
Source Type: Journal
DOI: 10.1507/endocrj.49.307 Document Type: Article |
Times cited : (26)
|
References (29)
|